Bioject to Report Second Quarter 2011 Financial Results

PORTLAND, Ore.--()--Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the second quarter ended June 30, 2011, on Wednesday, August 10, 2011, after the close of the financial markets. Management will conduct a conference call on Thursday, August 11, 2011 at 10:00 a.m. Eastern Daylight Time to review the results for the quarter.

Live audio of the conference call will be available to investors, members of the news media and the general public. To participate in the call via telephone, please dial 1-877-407-8037. A conference call replay will also be available until August 18, 2011. To listen to the replay, please dial 1-877-660-6853, replay account number 7303, identification number 376606.

Bioject Medical Technologies Inc., based in Portland, Oregon, USA, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS provide an empowering technology and work by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies, as well as research, global health and government organizations.

For more information about Bioject, visit www.bioject.com.

Contacts

Bioject Medical Technologies Inc.
Ralph Makar, 503-692-8001 ext. 4137
President and CEO
or
Christine M. Farrell, 503-692-8001 ext. 4132
Vice President of Finance

Contacts

Bioject Medical Technologies Inc.
Ralph Makar, 503-692-8001 ext. 4137
President and CEO
or
Christine M. Farrell, 503-692-8001 ext. 4132
Vice President of Finance